Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K van Besien

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Blood Cells|January 1, 1991
Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesisE F Srour, J E Brandt, R A Briddell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignanciesK van Besien, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Bone Marrow Transplantation|October 19, 2001
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisionsK van Besien, M Koshy, L Anderson-Shaw, et al.
Bone Marrow Transplantation|April 5, 2005
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromesP Kebriaei, J Kline, W Stock, et al.
Urology|December 1, 1995
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantationC Ippoliti, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|April 1, 1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicityK van Besien, J Tabocoff, M Rodriguez, et al.
Bone Marrow Transplantation|April 1, 1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantationD Przepiorka, C Ippoliti, A Panina, et al.
Bone Marrow Transplantation|September 12, 2000
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseK van Besien, A Bartholomew, W Stock, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Blood Cells|January 1, 1991
Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesisE F Srour, J E Brandt, R A Briddell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignanciesK van Besien, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Bone Marrow Transplantation|October 19, 2001
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisionsK van Besien, M Koshy, L Anderson-Shaw, et al.
Bone Marrow Transplantation|April 5, 2005
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromesP Kebriaei, J Kline, W Stock, et al.
Urology|December 1, 1995
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantationC Ippoliti, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|April 1, 1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicityK van Besien, J Tabocoff, M Rodriguez, et al.
Bone Marrow Transplantation|April 1, 1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantationD Przepiorka, C Ippoliti, A Panina, et al.
Bone Marrow Transplantation|September 12, 2000
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseK van Besien, A Bartholomew, W Stock, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Pageof 8